Filtros de búsqueda

Lista de obras de Vittorio Gebbia

A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study.

artículo científico publicado en 2001

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

artículo científico publicado en 2011

A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial.

artículo científico publicado en 2009

A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer

artículo científico publicado en 2013

A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer

artículo científico publicado en 2011

A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia

artículo científico publicado en 2012

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

artículo científico publicado en 2014

Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents.

artículo científico

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

artículo científico publicado en 2007

Adjuvant therapy in colon cancer.

artículo científico publicado en 2009

An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

scientific article published on 01 December 1995

Anticancer oral therapy: emerging related issues.

artículo científico publicado en 2010

Breakthrough pain in oncology: a longitudinal study.

artículo científico publicado en 2010

Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit.

artículo científico publicado en 2013

Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial

artículo científico publicado en 2008

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial

artículo científico publicado en 2011

Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials.

artículo científico publicado en 2010

Cetuximab in squamous cell head and neck carcinomas.

artículo científico publicado en 2007

Cetuximab: clinical results in colorectal cancer.

artículo científico publicado en 2007

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

artículo científico publicado en 2005

Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: a new highly active chemotherapeutic regimen

artículo científico publicado en 2001

Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).

artículo científico publicado en 2010

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Tr

artículo científico publicado en 2014

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials

artículo científico publicado en 2010

Does pain intensity predict a poor opioid response in cancer patients?

artículo científico publicado en 2011

Effect of human granulocyte colony stimulating factor (G-CSF) and reduced glutathione (GSH) on drug-induced leukopenia in golden Syrian hamsters

scientific article published on 01 September 1990

Efficacy and safety of cetuximab/irinotecan in chemotherapy-refractory metastatic colorectal adenocarcinomas: a clinical practice setting, multicenter experience

artículo científico publicado en 2006

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2012

Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule

artículo científico publicado en 1994

Evolution of therapy decision-making process for advanced non-small cell lung cancer

artículo científico publicado en 2009

FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)

artículo científico publicado en 2006

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial

artículo científico publicado en 2012

First-line treatment with epirubicin and vinorelbine in metastatic breast cancer

artículo científico publicado en 2002

Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).

artículo científico publicado en 2006

Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study

artículo científico publicado en 2000

Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical T

artículo científico publicado en 2003

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).

artículo científico publicado en 2013

Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamo

artículo científico publicado en 2011

Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.

artículo científico publicado en 2007

Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106).

artículo científico publicado en 2005

Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale.

artículo científico publicado en 2010

Italian clinical research in non-small-cell lung cancer

artículo científico publicado en 2005

Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study

artículo científico publicado en 2011

Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer

artículo científico publicado en 2009

Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study.

artículo científico publicado en 2010

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

scientific article published on 01 November 1998

Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer.

artículo científico publicado en 2005

New opioids

artículo científico

Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.

artículo científico publicado en 2005

Oral versus intravenous vinorelbine: clinical safety profile.

artículo científico publicado en 2005

Oral vinorelbine may not induce acute pain at the tumor site

scientific article published on 01 September 2006

Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation

artículo científico publicado en 2002

Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.

artículo científico publicado en 1996

Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer

scientific article published on 01 January 1991

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer.

artículo científico publicado en 2013

Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale

artículo científico publicado en 2005

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

artículo científico publicado en 2012

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

artículo científico publicado en 2012

Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas

artículo científico publicado en 2006

Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma

artículo científico publicado en 1996

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

artículo científico publicado en 2013

Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study

artículo científico publicado en 2010

Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial

artículo científico publicado en 2006

Salvage therapy with oral metronomic cyclophosphamide and methotrexate for castration-refractory metastatic adenocarcinoma of the prostate resistant to docetaxel

artículo científico publicado en 2011

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

artículo científico publicado en 2007

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management

artículo científico publicado en 2008

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

artículo científico publicado en 2015

Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anemia and role of recombinant human erythropoietin.

artículo científico publicado en 2003

The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy

artículo científico publicado en 2010

Thyroid cancer: different outcomes to chemotherapy according to tumour histology

scientific article published on 01 December 1995

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients

artículo científico publicado en 2009

Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer

artículo científico publicado en 2013

Treatment of advanced non-small cell lung cancer: chemotherapy with or without cisplatin?

artículo científico publicado en 2006

Treatment of metastatic breast cancer with vinorelbine and docetaxel

scientific article published on 01 June 2006

Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study

artículo científico publicado en 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda